7 terminated. 7 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 7 | Terminated 7 |
| Phase 2 | 2 | Terminated 2 |
Follow Suspensions: new trials by email Literature Review of Suspensions trials Research Report on Suspensions
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Learn About a Modified RNA Vaccine Against Shingles in Healthy Adults Candidate 1: PF-07915234: VZV modRNA Powder for Suspension for Injection, Candidate 1: PF-07915234: VZV modRNA Suspension for Injection, Candidate 2: PF-07921188: VZV modRNA Suspension for Injection - Shingles, Herpes Zoster Infection | Phase 1 / Phase 2 | Terminated | Pfizer | 484 | 2023-01-25 | 2026-05-04 |
| Biological Response to Platelet-rich Plasma and Corticosteroid Injections Triamcinolone Acetonide 40 mg/ml Inj, Susp, Platelet-rich plasma Inj - Knee Osteoarthritis | Phase 1 / Phase 2 | Terminated | University of Missouri-Columbia | 23 | 2022-12-28 | 2025-06-25 |
| COVID-19 Oral and Subcutaneous Vaccination Using a 2nd Generation (E1/E2B/E3-Deleted) Adenovirus Platform in Healthy Volunteers in USA hAd5-S-Fusion+N-ETSD (Suspension for injection), hAd5-SFusion+ N-ETSD (Oral capsule) - Covid19 | Phase 1 | Terminated | ImmunityBio, Inc. | 28 | 2021-02-24 | 2024-10-15 |
| Dose Escalation and Cohort Expansion Study of Niraparib and Dostarlimab in Paediatric Participants With Solid Tumors (SCOOP) Niraparib (Tablet for oral suspension), Dostarlimab, Niraparib (Tablet) - Neoplasms | Phase 1 | Terminated | GlaxoSmithKline | 47 | 2020-10-06 | 2026-01-21 |
| QUILT-3.013: Study of Ad5 [E1-, E2b-]-HER2/Neu Vaccine (ETBX-021) in Subjects With Unresectable Locally Advanced or Metastatic HER2-Expressing Breast Cancer ETBX-021 - Cancer | Phase 1 | Terminated | NantBioScience, Inc. | 3 | 2017-03-04 | 2025-01-13 |
| Bioavailability and Effect of Food on DSM265 Granules in Healthy Adult Subjects DSM265 50% SDD granules, DSM265 25% SDD powder for suspension - Healthy Volunteers, Bioavailability | Phase 1 | Terminated | Medicines for Malaria Venture | 11 | 2016-05-01 | 2016-09-14 |
| A Four-Way Cross-Over Study To Compare The Plasma Concentrations Of PF-02413873 After Oral Administration Of Several Doses As Suspension And As Tablets. 150 mg Suspension, 30 mg Suspension, 400 mg Suspension - Healthy | Phase 1 | Terminated | Pfizer | 12 | 2009-04-01 | 2018-12-07 |
Neoplasms (2) · Breast Neoplasms (1) · Breast Neoplasms, Male (1) · COVID-19 (1) · Chickenpox (1) · Herpes Zoster (1) · Neoplasm Metastasis (1) · Neuroblastoma (1) · Osteoarthritis (1) · Osteoarthritis, Knee (1) · Osteosarcoma (1)
Pfizer (2) · GlaxoSmithKline (1) · ImmunityBio, Inc. (1) · Medicines for Malaria Venture (1) · NantBioScience, Inc. (1) · University of Missouri-Columbia (1)
United States (5) · Singapore (1) · United Kingdom (1)
PMID 15039276, PMID 18587624, PMID 23559821, PMID 25035839, PMID 28287489, PMID 31901394, PMID 32551947, PMID 34505846, PMID 34945097